日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Adjuvant Treatment of Triple-Negative Metaplastic Breast Cancer With Weekly Paclitaxel and Platinum Chemotherapy: Retrospective Case Review From a Single Institution

采用每周紫杉醇和铂类化疗辅助治疗三阴性化生性乳腺癌：单中心回顾性病例分析

期刊:Clinical Breast Cancer
影响因子:2.5
doi:10.1016/j.clbc.2019.05.009
Harper, Natalie W; Hodges, Kurt B; Stewart, Rachel L; Wu, Jianrong; Huang, Bin; O'Connor, Kathleen L; Romond, Edward H
肿瘤
肿瘤免疫
乳腺癌
发表日期：2019
文献求助 收藏

Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2

NSABP B-31/NRG肿瘤方案中患者的心脏功能和生活质量长期随访：一项随机试验，比较多柔比星和环磷酰胺（AC）序贯紫杉醇与AC序贯紫杉醇和曲妥珠单抗治疗淋巴结阳性、肿瘤过表达人表皮生长因子受体2（HER2）的乳腺癌患者的安全性和有效性

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2017.74.1165
Ganz, Patricia A; Romond, Edward H; Cecchini, Reena S; Rastogi, Priya; Geyer, Charles E Jr; Swain, Sandra M; Jeong, Jong-Hyeon; Fehrenbacher, Louis; Gross, Howard M; Brufsky, Adam M; Flynn, Patrick J; Wahl, Tanya A; Seay, Thomas E; Wade, James L 3rd; Biggs, David D; Atkins, James N; Polikoff, Jonathan; Zapas, John L; Mamounas, Eleftherios P; Wolmark, Norman
肿瘤
HER2
肿瘤免疫
信号转导
乳腺癌
Human
发表日期：2017
文献求助 收藏

Body Mass Index at Diagnosis and Breast Cancer Survival Prognosis in Clinical Trial Populations from NRG Oncology/NSABP B-30, B-31, B-34, and B-38

NRG Oncology/NSABP B-30、B-31、B-34 和 B-38 临床试验人群中诊断时的体重指数与乳腺癌生存预后的关系

期刊:Cancer Epidemiology Biomarkers & Prevention
影响因子:3.4
doi:10.1158/1055-9965.EPI-15-0334-T
Cecchini, Reena S; Swain, Sandra M; Costantino, Joseph P; Rastogi, Priya; Jeong, Jong-Hyeon; Anderson, Stewart J; Tang, Gong; Geyer, Charles E Jr; Lembersky, Barry C; Romond, Edward H; Paterson, Alexander H G; Wolmark, Norman
肿瘤
肿瘤免疫
乳腺癌
发表日期：2016
文献求助 收藏

Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2-positive breast cancer: planned joint analysis of overall survival from NSABP B-31 and NCCTG N9831

曲妥珠单抗联合辅助化疗治疗人表皮生长因子受体 2 阳性乳腺癌：NSABP B-31 和 NCCTG N9831 研究的总生存期联合分析

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2014.55.5730
Perez, Edith A; Romond, Edward H; Suman, Vera J; Jeong, Jong-Hyeon; Sledge, George; Geyer, Charles E Jr; Martino, Silvana; Rastogi, Priya; Gralow, Julie; Swain, Sandra M; Winer, Eric P; Colon-Otero, Gerardo; Davidson, Nancy E; Mamounas, Eleftherios; Zujewski, Jo Anne; Wolmark, Norman
信号转导
肿瘤
肿瘤免疫
乳腺癌
发表日期：2014
文献求助 收藏

Impact of adding the multikinase inhibitor sorafenib to endocrine therapy in metastatic estrogen receptor-positive breast cancer.

在转移性雌激素受体阳性乳腺癌的内分泌治疗中加入多激酶抑制剂索拉非尼的影响

期刊:Future Oncology
影响因子:2.6
doi:10.2217/fon.14.99
Massarweh Suleiman, Moss Jessica, Wang Chi, Romond Edward, Slone Stacey, Weiss Heidi, Karabakhtsian Rouzan G, Napier Dana, Black Esther P
免疫/内分泌
乳腺癌
肿瘤免疫
发表日期：2014
文献求助 收藏

Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal growth factor receptor 2-positive breast cancer

NSABP B-31 是一项随机试验，比较了多柔比星和环磷酰胺序贯紫杉醇 (ACP) 方案与 ACP 联合曲妥珠单抗作为淋巴结阳性、人表皮生长因子受体 2 阳性乳腺癌患者的辅助治疗方案，并对其中 7 年随访期间的心脏功能进行了评估。

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2011.40.0010
Romond, Edward H; Jeong, Jong-Hyeon; Rastogi, Priya; Swain, Sandra M; Geyer, Charles E Jr; Ewer, Michael S; Rathi, Vikas; Fehrenbacher, Louis; Brufsky, Adam; Azar, Catherine A; Flynn, Patrick J; Zapas, John L; Polikoff, Jonathan; Gross, Howard M; Biggs, David D; Atkins, James N; Tan-Chiu, Elizabeth; Zheng, Ping; Yothers, Greg; Mamounas, Eleftherios P; Wolmark, Norman
信号转导
肿瘤
肿瘤免疫
乳腺癌
发表日期：2012
文献求助 收藏

Four-year follow-up of trastuzumab plus adjuvant chemotherapy for operable human epidermal growth factor receptor 2-positive breast cancer: joint analysis of data from NCCTG N9831 and NSABP B-31

曲妥珠单抗联合辅助化疗治疗可手术的人表皮生长因子受体2阳性乳腺癌的四年随访：NCCTG N9831和NSABP B-31数据的联合分析

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.2011.35.0868
Perez, Edith A; Romond, Edward H; Suman, Vera J; Jeong, Jong-Hyeon; Davidson, Nancy E; Geyer, Charles E Jr; Martino, Silvana; Mamounas, Eleftherios P; Kaufman, Peter A; Wolmark, Norman
信号转导
肿瘤
肿瘤免疫
乳腺癌
发表日期：2011
文献求助 收藏

Intratumoral delivery of Paclitaxel in solid tumor from biodegradable hyaluronan nanoparticle formulations

利用可生物降解的透明质酸纳米颗粒制剂将紫杉醇瘤内递送至实体瘤

期刊:AAPS PharmSciTech
影响因子:4
doi:10.1208/s12249-009-9222-5
Al-Ghananeem, Abeer M; Malkawi, Ahmad H; Muammer, Yahya M; Balko, Justin M; Black, Esther P; Mourad, Walid; Romond, Edward
发表日期：2009
文献求助 收藏